Great news for us! Malaysia has officially launched our very own COVID-19 test kit called ImmuSAFE which is able to detect and quantify an individual’s antibody protective level of the disease.
According to the news, ImmuSAFE is the world’s first lab-based; multi-antigen and multi-domain COVID-19 serology test which is examination of blood serum that enables high-throughput screening of COVID-19 samples for diagnosis of current or prior infection. The homegrown COVID-19 test kit was jointly developed by the Malaysia Automotive, Robotics and IoT Institute (MARii) and Sengenics Sdn Bhd.
MARii chief executive officer Datuk Madani Sahari said the test kit had a 100% sensitivity and specificity validated by the Institute of Medical Research (IMR), an agency under the Health Ministry (MOH).
ImmuSAFE can provide result within a few hours
Based on tests conducted on 5,000 samples during the development of ImmuSAFE, the test results could be obtained within a few hours, he explained.
However, he emphasised that ImmuSAFE test is not going to replace Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests. But, it is a supplementary test that can give a complete image whether a person has been infected.
The homegrown COVID-19 test kit and RT-PCR test could be use together to enhance the accuracy of the readings
“If ImmuSAFE test and RT-PCR are combined together, it would be the perfect solution to understand the status whether you are being infected or not with Covid-19.”
Nevertheless, they were still waiting for approval from the Medical Device Authority (MDA) under the MOH before it can be made available in the market.
Sengenics Sdn Bhd CEO Dr Arif Anwar shared that they spent about five months to develop ImmuSAFE test kits.
“We are proud to be a part of this partnership with MARii and IMR and appreciate the support and technical expertise of both parties throughout the development and validation of the Covid-19 test kit,” he said.